Media

 
Aromics launches a crowdfunding campaing for its mesothelioma drug

January 2017

Aromics launches a crowdfunding campaing for its mesothelioma drug

Aromics launches a ‘crowdfunding’ campaign to accelerate the development of a novel drug for the treatment of asbestos-related cancer. Visit http://www.capitalcell.net/investment/aromics23/ The goal of the campaign launched by AROMICS, located at the Barcelona Science Park, is completing regulatory preclinical package of the first-in-human clinical studies of its drug NAX035 for the treatment of malignant mesothelioma, an aggressive, poor prognosis and highly treatment-resistant asbestos-associated malignancy, directly linked to asbestos exposure.      

 
Spend the summer at Barcelona Science Park

August 2015

Spend the summer at Barcelona Science Park

AROMICS one of the participants in the 14th edition of "spend the summer at Park", a programe focussed on students' internships.

 
Biotechnology  in Barcelona: Interview with Dr Carmen Plasencia, CEO of AROMICS

April 2013

Biotechnology in Barcelona: Interview with Dr Carmen Plasencia, CEO of AROMICS

Dr. Ilaria Mirabille interviews Dr. Carmen Plasencia, CEO of AROMICS, a young Barcelona-based biotech, about the history of the company, its R&D activity as well as Dr. Plasencia's experience on starting and growing a company.

 
Biopol'H interview to Carme Plasencia, CEO of AROMICS

September 2011

Biopol'H interview to Carme Plasencia, CEO of AROMICS

In this interview Dr. Carmen Plasencia, SCO, explains AROMICS’ history, its R&D activity, as well as the services and main products offered to the Pharmaceutical Industry. Dr. Plasencia described ther experience on the creation of the start-up and the support recived by the Scientific Park of Barcelona.Latest interview of AROMICS in Biopol'H

 
AROMICS. BioNanoMed Catalunya Alliance

May 2011

AROMICS. BioNanoMed Catalunya Alliance

On the occasion of the public presentation of the BioNanoMed Catalunya Alliance, where AROMICS takes part, the television news bulletin of TV3, the public television of Catalonia, made a reportage covering the event and showing AROMICS as an example of a biotech company implementing nanotechnology in several of its developments in the diagnostic area.   More info about this initiative at http://www.bionanomedcat.org